- Home
- ALZN vs AWH Comparison
ALZN vs AWH Comparison
Compare ALZN & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- AWH
- Stock Information
- Founded
- ALZN 2016
- AWH 1993
- Country
- ALZN United States
- AWH United States
- Employees
- ALZN N/A
- AWH N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- AWH Medical/Dental Instruments
- Sector
- ALZN Health Care
- AWH Health Care
- Exchange
- ALZN Nasdaq
- AWH Nasdaq
- Market Cap
- ALZN 6.1M
- AWH 2.9M
- IPO Year
- ALZN 2021
- AWH N/A
- Fundamental
- Price
- ALZN $0.69
- AWH $0.15
- Analyst Decision
- ALZN Strong Buy
- AWH Buy
- Analyst Count
- ALZN 1
- AWH 2
- Target Price
- ALZN $32.00
- AWH $4.40
- AVG Volume (30 Days)
- ALZN 869.9K
- AWH 10.9M
- Earning Date
- ALZN 03-10-2025
- AWH 03-27-2025
- Dividend Yield
- ALZN N/A
- AWH N/A
- EPS Growth
- ALZN N/A
- AWH N/A
- EPS
- ALZN N/A
- AWH N/A
- Revenue
- ALZN N/A
- AWH $8,963,000.00
- Revenue This Year
- ALZN N/A
- AWH $11.87
- Revenue Next Year
- ALZN N/A
- AWH $79.10
- P/E Ratio
- ALZN N/A
- AWH N/A
- Revenue Growth
- ALZN N/A
- AWH N/A
- 52 Week Low
- ALZN $0.66
- AWH $0.12
- 52 Week High
- ALZN $15.06
- AWH $3.81
- Technical
- Relative Strength Index (RSI)
- ALZN 24.21
- AWH 30.23
- Support Level
- ALZN $0.66
- AWH $0.12
- Resistance Level
- ALZN $0.93
- AWH $0.36
- Average True Range (ATR)
- ALZN 0.07
- AWH 0.04
- MACD
- ALZN -0.01
- AWH 0.01
- Stochastic Oscillator
- ALZN 9.00
- AWH 14.00
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.